<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03006458</url>
  </required_header>
  <id_info>
    <org_study_id>CV-16-28 (C16-599)</org_study_id>
    <nct_id>NCT03006458</nct_id>
  </id_info>
  <brief_title>A Clinical Comparison of 2 Multifocal Toric XR (Extended Range) Contact Lenses</brief_title>
  <official_title>A Clinical Comparison of the Comfilcon A (Extended Range) XR Toric Multifocal and Omafilcon B Toric XR Multifocal Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare the clinical performance and subjective acceptance of the
      comfilcon A and the omafilcon B soft contact lenses.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a randomized, subject-masked, crossover, bilateral study, controlled by cross
      comparison. Thirty subjects will use each lens type for two weeks in random sequence.
      Follow-up visits for each lens will be performed after two weeks of wear. Lenses will be worn
      on a daily wear basis.

      The final optical design of comfilcon A contact lens was optimized to improve the quality and
      two further studies (CV-18-10 and CV-18-11) were conducted after completion of this study to
      evaluate the modified optical design.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Actual">April 6, 2017</completion_date>
  <primary_completion_date type="Actual">April 6, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stability</measure>
    <time_frame>Baseline</time_frame>
    <description>Investigator's acceptance on overall stability for comfilcon A and omafilcon B lenses assessed using grading scale 0-4, 0=Totally unstable, can't be worn to provide acceptable vision correction for astigmatism, 4=Excellent orientation and optimum rotational.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stability</measure>
    <time_frame>2 weeks</time_frame>
    <description>Investigator's acceptance on overall stability for comfilcon A and omafilcon B lenses assessed using grading scale 0-4, 0=Totally unstable, can't be worn to provide acceptable vision correction for astigmatism, 4=Excellent orientation and optimum rotational.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Toric Lens Fit Acceptance</measure>
    <time_frame>Baseline</time_frame>
    <description>Overall toric lens fit acceptance is assessed for comfilcon A and omafilcon B lenses. Scale 0-4, 0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=optimum.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Toric Lens Fit Acceptance</measure>
    <time_frame>2 weeks</time_frame>
    <description>Overall toric lens fit acceptance is assessed for comfilcon A and omafilcon B lenses. Scale 0-4, 0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=optimum.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comfort</measure>
    <time_frame>Baseline</time_frame>
    <description>Subjective ratings for comfort assessed. Scale 0-100, 0=cannot be worn, causes pain; 100=cannot be felt ever</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comfort</measure>
    <time_frame>2 weeks</time_frame>
    <description>Subjective ratings for comfort assessed. Scale 0-100, 0=cannot be worn, causes pain; 100=cannot be felt ever</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Satisfaction</measure>
    <time_frame>2 weeks</time_frame>
    <description>Subjective ratings for overall satisfaction for comfilcon A and omafilcon B lenses assessed. Scale 0-100, 0=extremely dissatisfied, 100=extremely satisfied</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dryness</measure>
    <time_frame>2 weeks</time_frame>
    <description>Subjective ratings for dryness assessed. Scale 0-100, 0=cannot be worn, extremely dry; 100=no dryness experienced at any time</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Fluctuation/ Stability</measure>
    <time_frame>2 weeks</time_frame>
    <description>Subjective ratings for visual fluctuation/stability assessed. Scale 0-100, 0=totally unstable/ fluctuation/changing; 100=perfectly stable/not fluctuation/changing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Handling</measure>
    <time_frame>2 weeks</time_frame>
    <description>Subjective ratings for handling difficulty assessed at 2 weeks. Scale 0-100, 0=very difficult, 100=very easy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of Near Vision</measure>
    <time_frame>2 weeks</time_frame>
    <description>Subjective ratings for quality of near vision. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of Intermediate Vision</measure>
    <time_frame>2 weeks</time_frame>
    <description>Subjective ratings for quality of intermediate vision. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of Distance Vision</measure>
    <time_frame>2 weeks</time_frame>
    <description>Subjective ratings for quality of distance vision. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of Vision While Driving During the Day</measure>
    <time_frame>2 weeks</time_frame>
    <description>Subjective rating for quality of vision while driving during the day. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of Vision While Driving During the Night</measure>
    <time_frame>2 weeks</time_frame>
    <description>Subjective ratings for quality of vision while driving at night. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ghosting at Near</measure>
    <time_frame>2 weeks</time_frame>
    <description>Subjective ratings for ghosting at near assessed at 2 weeks. Scale 0-100, 0=intolerable, 100=not noticeable.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ghosting at Distance</measure>
    <time_frame>2 weeks</time_frame>
    <description>Subjective ratings for ghosting at distance assessed at 2 weeks. Scale 0-100, 0=intolerable, 100=not noticeable.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>comfilcon A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study.
The final optical design of comfilcon A contact lens was optimized to improve the quality and two further studies (CV-18-10 and CV-18-11) were conducted after completion of this study to evaluate the modified optical design.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>omafilcon B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>comfilcon A</intervention_name>
    <description>toric contact lens</description>
    <arm_group_label>comfilcon A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>omafilcon B</intervention_name>
    <description>toric contact lens</description>
    <arm_group_label>omafilcon B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects will only be eligible for the study if:

               1. They are aged 40 - 70 years, inclusive.

               2. They understand their rights as a research subject and are willing and able to
                  sign a Statement of Informed Consent.

               3. They are willing and able to follow the protocol.

               4. They have successfully completed the non-dispensing study (C16-597) as the lenses
                  to be worn on this study (C16-599) are predetermined from their participation on
                  study C16-597.

               5. They have a contact lens spherical prescription between +10.00 to -10.00D
                  (Diopters) (inclusive).

               6. They have astigmatism between of -0.75 and -5.75DC (based on the calculated
                  ocular refraction) in each eye.

               7. They have an Add component to their spectacle refraction (between +0.75 and

                  +2.50DS).

               8. They can be satisfactorily fitted with the study lenses.

               9. They can attain at least 0.30 logMAR binocular distance high contrast visual
                  acuity with the study lenses within the available power range.

              10. They have successfully worn soft contact lenses in the last two years.

              11. They are willing to comply with the wear schedule (at least five days per week
                  and for at least six hours per day).

              12. They agree not to participate in other clinical research for the duration of this
                  study.

              13. They own a wearable pair of spectacles.

        Exclusion Criteria:

          -  Subjects will not be eligible to take part in the study if:

               1. They have an ocular disorder which would normally contra-indicate contact lens
                  wear.

               2. They have a systemic disorder which would normally contra-indicate contact lens
                  wear.

               3. They are using any topical medication such as eye drops or ointment.

               4. They have had cataract surgery.

               5. They have had corneal refractive surgery.

               6. They have any corneal distortion resulting from previous hard or rigid lens wear
                  or have keratoconus.

               7. They are pregnant or breast-feeding.

               8. They have any clinically meaningful slit lamp findings contraindicating contact
                  lens wear (e.g. â‰¥ Grade 3 finding of oedema, corneal neovascularisation, corneal
                  staining, tarsal abnormalities, conjunctival injection, blepharitis/meibomian
                  gland dysfunction) on the Efron classification scale or any other ocular
                  abnormality that in the opinion of the investigator would contraindicate contact
                  lens wear.

               9. They have any infectious disease (e.g. hepatitis) which would, in the opinion of
                  the investigator, contraindicate contact lens wear or pose a risk to study
                  personnel; or they have any immunosuppressive disease (e.g. HIV).

              10. They have a history of anaphylaxis or severe allergic reaction.

              11. They have taken part in any other contact lens or care solution clinical trial or
                  research, within two weeks prior to starting this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Eurolens Research</name>
      <address>
        <city>Manchester</city>
        <zip>M13 9PL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>December 27, 2016</study_first_submitted>
  <study_first_submitted_qc>December 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2016</study_first_posted>
  <results_first_submitted>April 29, 2020</results_first_submitted>
  <results_first_submitted_qc>May 15, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">June 1, 2020</results_first_posted>
  <disposition_first_submitted>December 19, 2019</disposition_first_submitted>
  <disposition_first_submitted_qc>December 19, 2019</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">December 24, 2019</disposition_first_posted>
  <last_update_submitted>May 15, 2020</last_update_submitted>
  <last_update_submitted_qc>May 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 2, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/58/NCT03006458/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Comfilcon A Then Omafilcon B</title>
          <description>Participants were randomized to wear comfilcon A for two weeks during the cross over study.
comfilcon A: toric contact lens</description>
        </group>
        <group group_id="P2">
          <title>Omafilcon B Then Comfilcon A</title>
          <description>Participants were randomized to wear omafilcon B for two weeks during the cross over study.
omafilcon B: toric contact lens</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Unsatisfied Vision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Second Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Overall Study</title>
          <description>Total Participants</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="24"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.2" spread="6.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Stability</title>
        <description>Investigator's acceptance on overall stability for comfilcon A and omafilcon B lenses assessed using grading scale 0-4, 0=Totally unstable, can't be worn to provide acceptable vision correction for astigmatism, 4=Excellent orientation and optimum rotational.</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A</title>
            <description>Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study.
comfilcon A: toric contact lens</description>
          </group>
          <group group_id="O2">
            <title>Omafilcon B</title>
            <description>Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study.
omafilcon B: toric contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Stability</title>
          <description>Investigator's acceptance on overall stability for comfilcon A and omafilcon B lenses assessed using grading scale 0-4, 0=Totally unstable, can't be worn to provide acceptable vision correction for astigmatism, 4=Excellent orientation and optimum rotational.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="1.5"/>
                    <measurement group_id="O2" value="2.9" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Stability</title>
        <description>Investigator's acceptance on overall stability for comfilcon A and omafilcon B lenses assessed using grading scale 0-4, 0=Totally unstable, can't be worn to provide acceptable vision correction for astigmatism, 4=Excellent orientation and optimum rotational.</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A</title>
            <description>Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study.
comfilcon A: toric contact lens</description>
          </group>
          <group group_id="O2">
            <title>Omafilcon B</title>
            <description>Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study.
omafilcon B: toric contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Stability</title>
          <description>Investigator's acceptance on overall stability for comfilcon A and omafilcon B lenses assessed using grading scale 0-4, 0=Totally unstable, can't be worn to provide acceptable vision correction for astigmatism, 4=Excellent orientation and optimum rotational.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="0.7"/>
                    <measurement group_id="O2" value="2.5" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Overall Toric Lens Fit Acceptance</title>
        <description>Overall toric lens fit acceptance is assessed for comfilcon A and omafilcon B lenses. Scale 0-4, 0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=optimum.</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A</title>
            <description>Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study.
comfilcon A: toric contact lens</description>
          </group>
          <group group_id="O2">
            <title>Omafilcon B</title>
            <description>Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study.
omafilcon B: toric contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Toric Lens Fit Acceptance</title>
          <description>Overall toric lens fit acceptance is assessed for comfilcon A and omafilcon B lenses. Scale 0-4, 0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=optimum.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="0.5"/>
                    <measurement group_id="O2" value="3.2" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Overall Toric Lens Fit Acceptance</title>
        <description>Overall toric lens fit acceptance is assessed for comfilcon A and omafilcon B lenses. Scale 0-4, 0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=optimum.</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A</title>
            <description>Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study.
comfilcon A: toric contact lens</description>
          </group>
          <group group_id="O2">
            <title>Omafilcon B</title>
            <description>Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study.
omafilcon B: toric contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Toric Lens Fit Acceptance</title>
          <description>Overall toric lens fit acceptance is assessed for comfilcon A and omafilcon B lenses. Scale 0-4, 0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=optimum.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" spread="0.6"/>
                    <measurement group_id="O2" value="2.8" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Comfort</title>
        <description>Subjective ratings for comfort assessed. Scale 0-100, 0=cannot be worn, causes pain; 100=cannot be felt ever</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A</title>
            <description>Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study.
comfilcon A: toric contact lens</description>
          </group>
          <group group_id="O2">
            <title>Omafilcon B</title>
            <description>Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study.
omafilcon B: toric contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort</title>
          <description>Subjective ratings for comfort assessed. Scale 0-100, 0=cannot be worn, causes pain; 100=cannot be felt ever</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.6" spread="20.3"/>
                    <measurement group_id="O2" value="79.7" spread="21.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Comfort</title>
        <description>Subjective ratings for comfort assessed. Scale 0-100, 0=cannot be worn, causes pain; 100=cannot be felt ever</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A</title>
            <description>Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study.
comfilcon A: toric contact lens</description>
          </group>
          <group group_id="O2">
            <title>Omafilcon B</title>
            <description>Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study.
omafilcon B: toric contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort</title>
          <description>Subjective ratings for comfort assessed. Scale 0-100, 0=cannot be worn, causes pain; 100=cannot be felt ever</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.8" spread="21.8"/>
                    <measurement group_id="O2" value="70.6" spread="27.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Overall Satisfaction</title>
        <description>Subjective ratings for overall satisfaction for comfilcon A and omafilcon B lenses assessed. Scale 0-100, 0=extremely dissatisfied, 100=extremely satisfied</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A</title>
            <description>Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study.
comfilcon A: toric contact lens</description>
          </group>
          <group group_id="O2">
            <title>Omafilcon B</title>
            <description>Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study.
omafilcon B: toric contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Satisfaction</title>
          <description>Subjective ratings for overall satisfaction for comfilcon A and omafilcon B lenses assessed. Scale 0-100, 0=extremely dissatisfied, 100=extremely satisfied</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.0" spread="31.4"/>
                    <measurement group_id="O2" value="63.3" spread="34.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Dryness</title>
        <description>Subjective ratings for dryness assessed. Scale 0-100, 0=cannot be worn, extremely dry; 100=no dryness experienced at any time</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A</title>
            <description>Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study.
comfilcon A: toric contact lens</description>
          </group>
          <group group_id="O2">
            <title>Omafilcon B</title>
            <description>Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study.
omafilcon B: toric contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Dryness</title>
          <description>Subjective ratings for dryness assessed. Scale 0-100, 0=cannot be worn, extremely dry; 100=no dryness experienced at any time</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.4" spread="24.7"/>
                    <measurement group_id="O2" value="77.2" spread="24.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Visual Fluctuation/ Stability</title>
        <description>Subjective ratings for visual fluctuation/stability assessed. Scale 0-100, 0=totally unstable/ fluctuation/changing; 100=perfectly stable/not fluctuation/changing</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A</title>
            <description>Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study.
comfilcon A: toric contact lens</description>
          </group>
          <group group_id="O2">
            <title>Omafilcon B</title>
            <description>Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study.
omafilcon B: toric contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Fluctuation/ Stability</title>
          <description>Subjective ratings for visual fluctuation/stability assessed. Scale 0-100, 0=totally unstable/ fluctuation/changing; 100=perfectly stable/not fluctuation/changing</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.0" spread="16.1"/>
                    <measurement group_id="O2" value="73.8" spread="25.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Handling</title>
        <description>Subjective ratings for handling difficulty assessed at 2 weeks. Scale 0-100, 0=very difficult, 100=very easy</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A</title>
            <description>Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study.
comfilcon A: toric contact lens</description>
          </group>
          <group group_id="O2">
            <title>Omafilcon B</title>
            <description>Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study.
omafilcon B: toric contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Handling</title>
          <description>Subjective ratings for handling difficulty assessed at 2 weeks. Scale 0-100, 0=very difficult, 100=very easy</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.5" spread="15.0"/>
                    <measurement group_id="O2" value="85.8" spread="17.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Quality of Near Vision</title>
        <description>Subjective ratings for quality of near vision. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A</title>
            <description>Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study.
comfilcon A: toric contact lens</description>
          </group>
          <group group_id="O2">
            <title>Omafilcon B</title>
            <description>Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study.
omafilcon B: toric contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Near Vision</title>
          <description>Subjective ratings for quality of near vision. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.5" spread="30.5"/>
                    <measurement group_id="O2" value="56.4" spread="28.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Quality of Intermediate Vision</title>
        <description>Subjective ratings for quality of intermediate vision. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A</title>
            <description>Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study.
comfilcon A: toric contact lens</description>
          </group>
          <group group_id="O2">
            <title>Omafilcon B</title>
            <description>Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study.
omafilcon B: toric contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Intermediate Vision</title>
          <description>Subjective ratings for quality of intermediate vision. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.2" spread="29.5"/>
                    <measurement group_id="O2" value="65.3" spread="25.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Quality of Distance Vision</title>
        <description>Subjective ratings for quality of distance vision. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A</title>
            <description>Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study.
comfilcon A: toric contact lens</description>
          </group>
          <group group_id="O2">
            <title>Omafilcon B</title>
            <description>Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study.
omafilcon B: toric contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Distance Vision</title>
          <description>Subjective ratings for quality of distance vision. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.2" spread="13.7"/>
                    <measurement group_id="O2" value="67.3" spread="25.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Quality of Vision While Driving During the Day</title>
        <description>Subjective rating for quality of vision while driving during the day. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A</title>
            <description>Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study.
comfilcon A: toric contact lens</description>
          </group>
          <group group_id="O2">
            <title>Omafilcon B</title>
            <description>Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study.
omafilcon B: toric contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Vision While Driving During the Day</title>
          <description>Subjective rating for quality of vision while driving during the day. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.3" spread="14.6"/>
                    <measurement group_id="O2" value="76.2" spread="25.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Quality of Vision While Driving During the Night</title>
        <description>Subjective ratings for quality of vision while driving at night. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A</title>
            <description>Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study.
comfilcon A: toric contact lens</description>
          </group>
          <group group_id="O2">
            <title>Omafilcon B</title>
            <description>Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study.
omafilcon B: toric contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Vision While Driving During the Night</title>
          <description>Subjective ratings for quality of vision while driving at night. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.0" spread="18.6"/>
                    <measurement group_id="O2" value="67.0" spread="23.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Ghosting at Near</title>
        <description>Subjective ratings for ghosting at near assessed at 2 weeks. Scale 0-100, 0=intolerable, 100=not noticeable.</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A</title>
            <description>Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study.
comfilcon A: toric contact lens</description>
          </group>
          <group group_id="O2">
            <title>Omafilcon B</title>
            <description>Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study.
omafilcon B: toric contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Ghosting at Near</title>
          <description>Subjective ratings for ghosting at near assessed at 2 weeks. Scale 0-100, 0=intolerable, 100=not noticeable.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.5" spread="35.0"/>
                    <measurement group_id="O2" value="78.1" spread="27.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Ghosting at Distance</title>
        <description>Subjective ratings for ghosting at distance assessed at 2 weeks. Scale 0-100, 0=intolerable, 100=not noticeable.</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A</title>
            <description>Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study.
comfilcon A: toric contact lens</description>
          </group>
          <group group_id="O2">
            <title>Omafilcon B</title>
            <description>Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study.
omafilcon B: toric contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Ghosting at Distance</title>
          <description>Subjective ratings for ghosting at distance assessed at 2 weeks. Scale 0-100, 0=intolerable, 100=not noticeable.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.3" spread="24.8"/>
                    <measurement group_id="O2" value="86.9" spread="24.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From baseline to follow up visit for an average of 2 weeks.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Comfilcon A</title>
          <description>Participants were randomized to wear comfilcon A toric lenses for two weeks during the cross over study.
comfilcon A: toric contact lens</description>
        </group>
        <group group_id="E2">
          <title>Omafilcon B</title>
          <description>Participants were randomized to wear omafilcon B toric lenses for two weeks during the cross over study.
omafilcon B: toric contact lens</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Myhanh Nguyen</name_or_title>
      <organization>CooperVision</organization>
      <phone>9257306716</phone>
      <email>MNguyen@coopervision.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

